About: Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 1997 (uk) article scientifique publié en 1997 (fr) im April 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1997 (ast) scientific article published on 01 April 1997 (en)
publication date	wds:Q73182990-6F158017-3B3C-4BB0-8C77-ED53C49392E2
publication date	1997-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73182990-66E92BB2-EB56-4D1A-817B-22BC9389F5BD
language of work or name	English
exact match	wds:Q73182990-13444161-51FF-470C-85F8-580B53DBDAEE
exact match	https://scigraph.springernature.com/pub.10.1038/ki.1997.162
cites work	wds:Q73182990-04432570-94CD-4174-8129-50FDE4C8C3EA wds:Q73182990-05B4BDBC-6055-4B6A-AE51-C850086E4655 wds:Q73182990-0B44E48C-47E4-4B8E-AA3E-05F84544A457 wds:Q73182990-12ED5E4F-AE57-47EA-8499-4E965A5B38BE wds:Q73182990-14EAB037-27B1-445C-B4FB-9EE104B7C2E8 wds:Q73182990-23A4CDFD-E61D-4562-AA8A-B4D125EA16DC wds:Q73182990-25F3EBC1-ED30-4702-A016-E009BCC8B285 wds:Q73182990-2D0F5425-5346-49B7-BB38-B1D7BBB0105A wds:Q73182990-2F71B78F-2387-478A-AE4A-82DD087E35F5 wds:Q73182990-3D2AFBF0-28D5-4AA4-80B2-AF2E693CD249 wds:Q73182990-48632E26-CB54-4540-A05C-991DEECB3AD9 wds:Q73182990-5A69660A-0D77-483B-825D-437E299C026A wds:Q73182990-6F447406-7739-4699-BFC8-5BCA0CAE9ED3 wds:Q73182990-71F70C8A-5185-4FB8-A70B-25F577D85CEF wds:Q73182990-7A66F262-98A9-4CE8-B5FF-E07B524990D7 wds:Q73182990-7C6A654B-A252-4237-B9C4-9C2E4983C668 wds:Q73182990-9298CF3B-5089-483D-8D5B-06855C725E07 wds:Q73182990-9C63FC7B-4329-4429-95F0-515216C716F3 wds:Q73182990-9E63E35C-2617-4274-9492-4634B3C2D0AD wds:Q73182990-A0198FA2-1487-4D7E-A55E-94E8958E2D99 wds:Q73182990-A6F1C21E-91EF-4292-8055-A2D9178F0180 wds:Q73182990-A8A6F53D-0B2A-4827-9734-D041DD6D11C9 wds:Q73182990-BD1D98BE-35E0-40F8-BB48-5CADA4F2A5ED wds:Q73182990-C2581560-6BF3-467A-9CBD-966516AE9AB9 wds:Q73182990-C276708A-D587-4DB5-98BF-57D8F649D7DC wds:Q73182990-C62297CB-1F4E-415D-A290-8F4080A8ED2C wds:Q73182990-CB1ECAE6-BB15-47B5-A83D-AC03A3AB7C4A wds:Q73182990-E4C8CFA6-66FE-4F1F-8B79-BDA49CC4D102 wds:Q73182990-E6C8CD0D-20B1-4A3F-9B68-E0D5A8FA03F8 wds:Q73182990-E71DA637-8875-4992-A70D-B5BA6313B482 wds:Q73182990-F6ACB9C8-30C2-471B-A656-13C5D4A17498
cites work	The prognosis of lupus nephritis in African-Americans: a retrospective analysis Epidemiologic studies on systemic lupus erythematosus comparative data for new york city and jefferson county, alabama, 1956–1965 The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis Prognostic factors in lupus nephritis. Contribution of renal histologic data Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data Nonparametric Estimation from Incomplete Observations Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death Nervous system involvement in systemic lupus erythematosus The 1982 revised criteria for the classification of systemic lupus erythematosus Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans The treatment of lupus nephritis by methyl prednisolone pulse therapy Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus Renal histology and clinical course of systemic lupus erythematosus. A prospective study Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease Clinical features of systemic lupus erythematosus: differences related to race and age of onset Lupus nephritis. Clinical course as related to morphologic forms and their transitions Prognostic determinants in lupus nephritis: a long-term clinicopathologic study Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis Intermittent intravenous cyclophosphamide therapy for lupus nephritis. The prognosis of lupus nephritis. Role of clinical-pathologic correlations Survivorship in systemic lupus erythematosus: relationship to race and pregnancy
author name string	wds:Q73182990-790B9C6D-0875-4E1C-B3C1-501111D41371 wds:Q73182990-85E346C3-7D6A-4012-AB3A-249D813FA92D wds:Q73182990-AB1BA576-ABAD-4F15-A568-52A47D1CF4E9 wds:Q73182990-FA2622B1-B890-4B4B-B4E2-2823B097C483
author name string	M A Dooley R Falk S Hogan C Jennette
rdfs:label	Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network (en) Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network (nl)
skos:prefLabel	Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network (en) Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network (nl)
name	Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network (en) Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network (nl)
title	wds:Q73182990-64FC5D70-DC8B-4830-9702-2FF0C335E4BE
title	Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network (en)
page(s)	wds:Q73182990-030F1DFF-DE8D-4C9D-8783-8D9ABC13B375
page(s)	1188-1195
instance of	wds:Q73182990-E76121CE-48E6-4B58-843A-C799AEEA52A0
instance of	scholarly article
main subject	wds:Q73182990-A628E84C-148B-4067-9F44-C2EAA6AD0838
main subject	lupus nephritis
PubMed ID	wds:Q73182990-2D0EE806-71A6-4609-A49F-EF33010F707D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9083285
PubMed ID	9083285

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software